These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25901200)

  • 1. Proteasome inhibition enhances the killing effect of BikDD gene therapy.
    Sun Y; Ponz-Sarvise M; Chang SS; Chang WC; Chen CH; Hsu JL; Hung MC
    Am J Transl Res; 2015; 7(2):319-27. PubMed ID: 25901200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective expression of constitutively active pro-apoptotic protein BikDD gene in primary mammary tumors inhibits tumor growth and reduces tumor initiating cells.
    Rahal OM; Nie L; Chan LC; Li CW; Hsu YH; Hsu J; Yu D; Hung MC
    Am J Cancer Res; 2015; 5(12):3624-34. PubMed ID: 26885451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted expression of BikDD eliminates breast cancer with virtually no toxicity in noninvasive imaging models.
    Xie X; Li L; Xiao X; Guo J; Kong Y; Wu M; Liu W; Gao G; Hsu JL; Wei W; Hung MC; Xie X
    Mol Cancer Ther; 2012 Sep; 11(9):1915-24. PubMed ID: 22752427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-targeted BikDD gene therapy elicits protective antitumor immunity against lung cancer.
    Sher YP; Liu SJ; Chang CM; Lien SP; Chen CH; Han Z; Li LY; Chen JS; Wu CW; Hung MC
    Mol Cancer Ther; 2011 Apr; 10(4):637-47. PubMed ID: 21282355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models.
    Xie X; Xia W; Li Z; Kuo HP; Liu Y; Li Z; Ding Q; Zhang S; Spohn B; Yang Y; Wei Y; Lang JY; Evans DB; Chiao PJ; Abbruzzese JL; Hung MC
    Cancer Cell; 2007 Jul; 12(1):52-65. PubMed ID: 17613436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted expression of BikDD combined with metronomic doxorubicin induces synergistic antitumor effect through Bax activation in hepatocellular carcinoma.
    Dai HY; Chen HY; Lai WC; Hung MC; Li LY
    Oncotarget; 2015 Sep; 6(27):23807-19. PubMed ID: 26247632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BikDDA, a mutant of Bik with longer half-life expression protein, can be a novel therapeutic gene for triple-negative breast cancer.
    Jiao S; Wu M; Ye F; Tang H; Xie X; Xie X
    PLoS One; 2014; 9(3):e92172. PubMed ID: 24637719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted hepatocellular carcinoma proapoptotic BikDD gene therapy.
    Li LY; Dai HY; Yeh FL; Kan SF; Lang J; Hsu JL; Jeng LB; Chen YH; Sher YP; Lin WC; Hung MC
    Oncogene; 2011 Apr; 30(15):1773-83. PubMed ID: 21151169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model.
    Day CP; Rau KM; Qiu L; Liu CW; Kuo HP; Xie X; Lopez-Berestein G; Hortobagyi GN; Hung MC
    Cancer Gene Ther; 2006 Jul; 13(7):706-19. PubMed ID: 16514421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant Bik gene transferred by cationic liposome inhibits peritoneal disseminated murine colon cancer.
    Lan KL; Yen SH; Liu RS; Shih HL; Tseng FW; Lan KH
    Clin Exp Metastasis; 2007; 24(6):461-70. PubMed ID: 17636408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition.
    Cusack JC; Liu R; Houston M; Abendroth K; Elliott PJ; Adams J; Baldwin AS
    Cancer Res; 2001 May; 61(9):3535-40. PubMed ID: 11325813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted endostatin-cytosine deaminase fusion gene therapy plus 5-fluorocytosine suppresses ovarian tumor growth.
    Sher YP; Chang CM; Juo CG; Chen CT; Hsu JL; Lin CY; Han Z; Shiah SG; Hung MC
    Oncogene; 2013 Feb; 32(9):1082-90. PubMed ID: 22562248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in combination with proteasome inhibitors.
    Diallo JS; Betton B; Parent N; Péant B; Lessard L; Le Page C; Bertrand R; Mes-Masson AM; Saad F
    Br J Cancer; 2008 Nov; 99(10):1613-22. PubMed ID: 18941459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beclin 1 enhances proteasome inhibition-mediated cytotoxicity of thyroid cancer cells in macroautophagy-independent manner.
    Zhang HY; Du ZX; Meng X; Zong ZH; Wang HQ
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E217-26. PubMed ID: 23264393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the ubiquitin-proteasome pathway in cancer therapy.
    Ishii Y; Waxman S; Germain D
    Anticancer Agents Med Chem; 2007 May; 7(3):359-65. PubMed ID: 17504161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors.
    Zhu H; Zhang L; Dong F; Guo W; Wu S; Teraishi F; Davis JJ; Chiao PJ; Fang B
    Oncogene; 2005 Jul; 24(31):4993-9. PubMed ID: 15824729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome inhibition elicits a biphasic effect on neuronal apoptosis via differential regulation of pro-survival and pro-apoptotic transcription factors.
    Butts BD; Hudson HR; Linseman DA; Le SS; Ryan KR; Bouchard RJ; Heidenreich KA
    Mol Cell Neurosci; 2005 Oct; 30(2):279-89. PubMed ID: 16112871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
    Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
    Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of proteasome function induced apoptosis in gastric cancer.
    Fan XM; Wong BC; Wang WP; Zhou XM; Cho CH; Yuen ST; Leung SY; Lin MC; Kung HF; Lam SK
    Int J Cancer; 2001 Aug; 93(4):481-8. PubMed ID: 11477551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of apoptosis proteins in cancer cells by ubiquitin.
    Zhang HG; Wang J; Yang X; Hsu HC; Mountz JD
    Oncogene; 2004 Mar; 23(11):2009-15. PubMed ID: 15021888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.